Abstract
We describe a case of eruptive pseudoangiomatosis triggered by the oral contraceptive Minulet® containing gestodene and ethinyloestradiol. A possible immunological mechanism in the induction of the skin lesions is suggested by the histopathological findings and a positive macrophage migration inhibition factor (MIF) test for the progesterone components in Minulet®.
Original language | English |
---|---|
Pages (from-to) | 259-261 |
Number of pages | 3 |
Journal | Journal of the European Academy of Dermatology and Venereology |
Volume | 9 |
Issue number | 3 |
DOIs | |
State | Published - 1997 |
Externally published | Yes |
Keywords
- Eruptive pseudoangiomatosis
- Gestodene
- Minulet®
- Oral contraceptive